Department of Medicine

Department of Medicine

  Division of Hematology/Oncology

[Return To Index page]
photo Rachel C. Jankowitz, MD

Assistant Professor, Department of Medicine, Division of Hematology/Oncology

Medical Director, Magee-Womens Hospital High Risk Breast Cancer Program


Phone: 412-641-4530

Office: Magee-Womens Hospital
300 Halket Street, Room 3524
Pittsburgh, PA 15213
Phone: 412-641-4530
Fax: 412-641-6461
Administrative Assistant:
Lisa Davis
Address: Magee Womens Hospital
300 Halkett Street
Pittsburgh, PA 15213
Phone: 412-641-6500
Fax: 412-641-6461
Education and Training
MD, Temple University School of Medicine, Philadelphia, PA
Residency, University of Pittsburgh Medical Center
Hematology Oncology Fellowship, University of Pittsburgh School of Medicine
Research Interest
Dr. Jankowitz is an Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine. She has served as a PI or co-investigator on multiple breast cancer clinical trials. Her areas of research include the study of invasive lobular carcinoma (ILC), including an ongoing clinical trial examining endocrine response in invasive lobular carcinoma, (effort supported by a Komen Career Catalyst Award) and a comprehensive database of ILC. She also is the co-PI of the Cancer Family Registry for Research and Surveillance (CFR, IRB#0406182), an established registry and specimen bank to facilitate multidisciplinary research related to individuals with family history concerning for hereditary breast and/or ovarian cancer.
Clinical Interest
Rachel C. Jankowitz, MD, is a medical oncologist at the University of Pittsburgh Cancer Institute. Dr Jankowitz received her medical degree from Temple University School of Medicine in Philadelphia, PA. She completed her residency in internal medicine and fellowship in hematology-oncology at the University of Pittsburgh. Dr Jankowitz specializes in breast cancer medical oncology and primary prevention of breast cancer. She sees breast cancer patients at UPMC Magee Womens Hospital as well as high-risk breast cancer patients at the Hillman Cancer Center. Her research interests include invasive lobular carcinoma, primary prevention of breast cancer, and epigenetics.
Educational Interest
As an Assistant Professor in the University of Pittsburgh School of Medicine, Dr. Jankowitz is actively involved in teaching various trainees in the inpatient and outpatient setting, including medical students, residents and fellows. She also serves as a mentor to trainees involved in various research projects
For my complete bibliography, Click Here.
Selected Publications:
Logan GJ, Dabbs DJ, Lucas PC, Jankowitz RC, Brown DD, Clark BZ, Oesterreich S, McAuliffe PF. Molecular drivers of lobular carcinoma in situ. Breast Cancer Research. 2105; 17: 76.
Prasad C, Greespan SL, Vujenivh KT, Burfsky A, Lembersky BC, va Londen GJ, Jankowitz RC, Puhalla SL, Rastogi P, Perera S. Metastatic HER2-Positive Breast Cancer: Tailoring Treatment Un-'TIL' We Get It Right... Bone. 2016; 90: 123-126.
Katz TA, Huang Y, Davidson NE, Jankowitz RC. Epigenetic reprogramming in breast cancer: from new targets to new therapies. Annuls of Medicine. 2014; 46(6): 397-408.
Jankowitz RC, Davidson NE. Adjuvant endocrine therapy for breast cancer: how long is long enough?. Oncology. 2013; 27(12): 1210-6.
Jankowitz RC, Abraham J, Tan AR, Limentani SA, Tierno MB, Adamson LM, Buyse M, Wolmark N, Jacobs SA. Safety and efficacy of neratinib in combination with weekly paclitaxel and trastuzumab in women with metastatic HER2 positive breast cancer: an NSABP Foundation Research Program phase I study. Cancer Chemotherapy and Pharmacology. 2013; 72(6): 1205-112.
Jankowitz RC, Lee AV. The evolving role of multi-gene tests in breast cancer management. Oncology. 2013; 3: 210-214.
Sikora MJ, Jankowitz RC, Dabbs DJ, Oesterreich S. Invasive lobular carcinoma of the breast: patient response to systemic endocrine therapy and hormone response in model systems. Steroids. 2013; 8(6): 568-75.
Jankowitz RC, Cooper K, Erlander MG, Ma XJ, Kesty NC, Li H, Chivukula M, Brufsky A. Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer. Journal of the National Cancer Institute. 2011; 13(4): 98.
Notable Achievements
ASCO Gianni Bonadonna Breast Cancer Research Fellowship, 2010